Avitas Wealth Management LLC Abbott Laboratories Transaction History

Avitas Wealth Management LLC

$674 Million
Q2 2024

A detailed history of Avitas Wealth Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Avitas Wealth Management LLC holds 28,265 shares of ABT stock, worth $3.18 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

28,265

Previous 28,630 1.27%

Holding current value

$3.18 Million

Previous $3.25 Million 9.74%

% of portfolio

0.44%

Previous 0.5%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$100.73 - $112.44 $36,766 - $41,040	-365 Reduced 1.27%	28,265 $2.94 Million
Q1 2024 Apr 24, 2024	SELL	$109.52 - $120.96 $56,950 - $62,899	-520 Reduced 1.78%	28,630 $3.25 Million
Q4 2023 Jan 24, 2024	BUY	$90.19 - $110.4 $11,003 - $13,468	122 Added 0.42%	29,150 $3.21 Million
Q3 2023 Nov 02, 2023	SELL	$95.53 - $114.62 $60,948 - $73,127	-638 Reduced 2.15%	29,028 $2.81 Million
Q2 2023 Jul 18, 2023	SELL	$100.78 - $112.29 $33,660 - $37,504	-334 Reduced 1.11%	29,666 $3.23 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $33,901 - $39,903	-350 Reduced 1.15%	30,000 $3.04 Million
Q4 2022 Jan 10, 2023	BUY	$95.06 - $111.52 $483,094 - $566,744	5,082 Added 20.11%	30,350 $0
Q3 2022 Oct 27, 2022	SELL	$96.76 - $112.03 $348,819 - $403,868	-3,605 Reduced 12.49%	25,268 $2.45 Million
Q2 2022 Jul 29, 2022	SELL	$102.07 - $123.37 $724,492 - $875,680	-7,098 Reduced 19.73%	28,873 $3.14 Million
Q1 2022 Apr 28, 2022	SELL	$114.02 - $139.04 $665,990 - $812,132	-5,841 Reduced 13.97%	35,971 $4.26 Million
Q4 2021 Jan 26, 2022	BUY	$115.53 - $141.46 $1.17 Million - $1.44 Million	10,166 Added 32.12%	41,812 $5.89 Million
Q3 2021 Oct 28, 2021	BUY	$116.66 - $129.06 $846,601 - $936,588	7,257 Added 29.76%	31,646 $3.74 Million
Q2 2021 Jul 12, 2021	BUY	$105.79 - $124.53 $58,078 - $68,366	549 Added 2.3%	24,389 $2.83 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $188,293 - $221,837	-1,730 Reduced 6.77%	23,840 $2.86 Million
Q4 2020 Feb 26, 2021	SELL	$105.0 - $114.42 $5,145 - $5,606	-49 Reduced 0.19%	25,570 $2.8 Million
Q3 2020 Oct 06, 2020	SELL	$91.64 - $111.29 $22,910 - $27,822	-250 Reduced 0.97%	25,619 $2.79 Million
Q2 2020 Jul 30, 2020	SELL	$76.57 - $98.0 $71,746 - $91,826	-937 Reduced 3.5%	25,869 $2.37 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $512,674 - $749,669	-8,161 Reduced 23.34%	26,806 $2.12 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $25,751 - $28,667	328 Added 0.95%	34,967 $3.04 Million
Q3 2019 Oct 18, 2019	BUY	$81.84 - $88.74 $39,283 - $42,595	480 Added 1.41%	34,639 $2.9 Million
Q2 2019 Jul 23, 2019	BUY	$72.88 - $85.0 $2.49 Million - $2.9 Million	34,159 New	34,159 $2.87 Million

Others Institutions Holding ABT

# of Institutions

3,137

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avitas Wealth Management LLC with notifications on news.

Account

Avitas Wealth Management LLC Abbott Laboratories Transaction History